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Key questions
What is already known?
 ► Many low-income countries have adopted perfor-
mance payments in the form of results-based fi-
nancing (RBF) programmes to improve quality and 
utilisation of maternal health services.
 ► Current evidence on RBF impact is largely focused 
on immediate or intermediate health service out-
comes (ie, service utilisation, service quality), but 
remains so far rather inconclusive.
What are the new findings?
 ► Our findings suggest that RBF programs with a 
strong focus on quality of service delivery and in 
combination with demand-side interventions can 
play a role in reducing maternal mortality, in settings 
with high utilisation of facility-based childbirth ser-
vices but inadequate service quality.
 ► This study provides further insight into how health-fi-
nancing interventions implemented in low-income 
settings require several years before reaching full 
operational capacity.
What do the new findings imply?
 ► Selection and evaluation of performance incentives 
might require a stronger focus on their actual contri-
bution to population health outcomes.
AbsTrACT
Introduction The aim of this study was to assess the 
impact of a results-based financing (RBF) programme 
on the reduction of facility-based maternal mortality at 
birth. Malawi is a low-income country with high maternal 
mortality. The Results-Based Financing For Maternal and 
Newborn Health (RBF4MNH) Initiative was introduced at 
obstetric care facilities in four districts to improve quality 
and utilisation of maternal and newborn health services. 
The RBF4MNH Initiative was launched in April 2013 as a 
combined supply-side and demand-side RBF. Programme 
expansion occurred in October 2014.
Methods Controlled interrupted time series was used 
to estimate the effect of the RBF4MNH on reducing 
facility-based maternal mortality at birth. The study 
sample consisted of all obstetric care facilities in 4 
intervention and 19 control districts, which constituted 
all non-urban mainland districts in Malawi. Data for 
obstetric care facilities were extracted from the Malawi 
Health Management Information System. Facility-based 
maternal mortality at birth was calculated as the number 
of maternal deaths per all deliveries at a facility in a given 
time period.
results The RBF4MNH effectively reduced facility-
based maternal mortality by 4.8 (−10.3 to 0.7, p<0.1) 
maternal deaths/100 000 facility-based deliveries/
month after reaching full operational capacity in October 
2014. Immediate effects (changes in level rather than 
slope) attributable to the RBF4MNH were not statistically 
significant.
Conclusion This is the first study evaluating the effect 
of a combined supply-side and demand-side RBF on 
maternal mortality outcomes and demonstrates the 
positive role financial incentives can play in improving 
health outcomes. This study further shows that 
timeframes spanning several years might be necessary to 
fully evaluate the impact of health-financing programmes 
on health outcomes. Further research is needed to assess 
the extent to which the observed reduction in facility-
based mortality at birth contributes to all-cause maternal 
mortality in the country.
InTroduCTIon
Although maternal deaths have decreased 
globally, sub-Saharan Africa (SSA) remains 
the region with the highest maternal mortality 
ratio (MMR), with 546 deaths per 100 000 
live births in 2015.1 The majority of maternal 
deaths are attributable to direct obstetric 
causes, such as haemorrhage, eclampsia, 
puerperal sepsis or obstructed labour.2 In 
most African settings, lack of access to care 
(due to financial and distance barriers) and 
poor health service delivery are key factors 
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hampering countries’ ability to adequately address the 
underlying clinical causes of maternal mortality.3
In recent years, results-based financing (RBF) has 
caught traction as a health system strengthening approach 
in improving both utilisation and quality of health 
services in low-income countries (LICs).4 RBF refers 
to a set of financial arrangements linking payments to 
defined healthcare outputs (eg, performance payments 
for service providers) or health-seeking behaviours (eg, 
conditional cash transfers (CCT) or vouchers for service 
users).5 Many LIC health systems therefore adopted 
RBF to gain further improvements in the utilisation and 
quality of primary care services, especially those related to 
maternal and newborn health (MNH). Current evidence 
on the effect of RBF is rather inconclusive given the 
differences in implementation contexts, and furthermore 
focused on immediate or intermediate health service 
outcomes, such as service utilisation, health worker moti-
vation, patient satisfaction and clinical quality.6 7 While 
few authors have looked at the impact of RBF on ultimate 
MNH outcomes, such as mortality, this work has almost 
exclusively addressed demand-side RBF programmes (ie, 
use of RBF to improve service utilisation).8–10 It follows 
that, to date, there is no clear evidence available on 
the causality between supply-side RBF programmes (ie, 
use of RBF to improve service provision) and maternal 
mortality reduction in SSA.
Our study contributes towards filling this knowledge 
gap by presenting results from a quasi-experimental 
impact evaluation of an RBF intervention on facili-
ty-based maternal mortality in Malawi. Our work is based 
on the assumption that the current evidence on RBF falls 
short to gauge the ultimate role RBF programmes can 
play in improving MNH outcomes in LIC. As a result, we 
postulate that comprehensive assessments of RBF ought 
to include analyses of its impact on relevant mortality 
indicators. Moreover, using exclusively routine data for 
our analysis, we demonstrate the feasibility of secondary 
data for RBF impact evaluations.
MeTHods
study setting
Malawi is an LIC in SSA with an estimated MMR of 
439 deaths per 100 000 live births in 2015.11 Obstetric 
care services are provided through the country’s essen-
tial health package offered free of charge at public and 
contracted not-for-profit health facilities.12 In 2015, 91% 
of births occurred in health facilities, with 90% of births 
attended by a skilled provider.11 In 2014, unmet need for 
emergency obstetric care (EmOC) among women with 
obstetric complications was estimated at 75%, given the 
majority of health facilities failed to fully meet the appli-
cable EmOC standards.13 Shortages in human resources 
and stock-outs of essential drugs and supplies further 
challenge the health system’s ability to reliably provide 
EmOC.
Intervention design
In April 2013, the Ministry of Health launched the 
Results-Based Financing For Maternal and Newborn 
Health (RBF4MNH) Initiative in four districts (Balaka, 
Dedza, Mchinji, Ntcheu) to improve quality and utili-
sation of facility-based childbirth care services.14 15 The 
RBF4MNH includes two components: (1) performance 
contracts with facilities and district health management 
teams (DHMTs) linked to defined childbirth care quality 
targets; and (2) CCT to pregnant women linked to giving 
birth and spending a 48-hour postpartum observation 
period at their respective catchment facility.14 15 District 
selection was non-random and a result of a political deci-
sion specifically supporting districts with weaker maternal 
health outcomes and EmOC structures.
The RBF4MNH was rolled out at the facility level. 
Initially, 18 non-randomly selected EmOC facilities (4 
hospitals, 14 health centres) across the 4 districts received 
RBF (ie, intervention phase 1). In October 2014, 15 addi-
tional EmOC facilities (3 hospitals, 12 health centres) 
were added within the same districts (ie, intervention 
phase 2). Facilities received performance payments 
in addition to their usual budget allocation. As part of 
RBF, most facilities also benefited from upfront invest-
ments in minor infrastructure repair or essential equip-
ment procurement (eg, renovation of labour rooms, 
purchase of disinfectants, replacement of blood pressure 
machines). Previous research related to the RBF4MNH 
demonstrated positive effects of the programme on clin-
ical performance and supply chain management,16 an 
overall positive but statistically non-significant impact on 
effective coverage of pregnant women with obstetric care 
services,17 a significant improvement in the timelines of 
care-seeking for women with pregnancy-related compli-
cations,18 and no evidence for the erosion of overall 
intrinsic health worker motivation.19
study design and outcome variable
Our study adopted a quasi-experimental approach based 
on an interrupted time series (ITS) design with inde-
pendent controls.20 We used monthly data on the number 
of direct infacility maternal deaths (ie, occurred during 
intrapartum or early postpartum period) and deliveries 
(ie, excluding abortions and miscarriages) reported by 
obstetric care facilities into the District Health Informa-
tion System version 2 (DHIS-2)-based national health 
management information system and computed facili-
ty-based maternal mortality at time of birth as the outcome 
variable. Beyond the lack of reliable population-based 
maternal mortality data in our study setting, we preferred 
this facility-based outcome because it better reflects the 
RBF4MNH theory of change, which targeted specifically 
effective childbirth care coverage at time of birth. Our 
outcome variable, facility-specific maternal mortality at 
birth per month, was calculated as the following:
 
Number of maternal deaths at birth per month in facility
Number of deliveries per month in facility × 100, 000 
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To estimate the impact of the RBF4MNH on facility-based 
maternal deaths at birth, we compared monthly mortality 
ratios over consecutive time points between all obstetric 
care facilities in the 4 intervention districts (Balaka, 
Dedza, Mchinji, Ntcheu) and all obstetric care facilities in 
19 out of the country’s remaining 25 districts as controls 
(district of ‘Nkhata Bay and Likoma’ treated as two sepa-
rate districts). We excluded six control districts due to 
lack of a priori comparability: the four urban districts of 
Blantyre, Lilongwe, Mzuzu and Zomba, and the island 
districts of Likoma and Mwanza. Based on the 2015/2016 
Democratic Health Survey, averages across districts for 
both use of facility-based delivery services and accessi-
bility of skilled birth attendants are comparable between 
intervention and control districts (93.5% vs 93.7% and 
90.5% vs 90.3%, respectively).11
We decided to compare estimates aggregated at the 
district rather than at the facility level for two reasons: 
first, to account for the substantially higher number 
of deaths reported by hospitals compared with health 
centres, as risk profiles inevitably differ across levels of 
care; second, to account for the fact that RBF4MNH 
performance contracts in the four intervention districts 
also targeted each DHMT, linking incentives to quality of 
service delivery in the districts at large. Given this partic-
ular intervention feature, we postulated the existence of 
a district effect due to spillover to non-RBF facilities.
data extraction and cleaning
For each facility, monthly data points were extracted 
from the Health Management Information System (HMIS) for 
a total period of 57 consecutive months starting July 2012 
(ie, 9 months before RBF4MNH launch) and ending 
March 2017 (ie, 48 months after RBF4MNH launch). 
During data preparation, we omitted all data points 
that were of irretrievably poor quality (eg, number of 
maternal deaths reported higher than number of deliv-
eries), three individual data points judged as outliers (ie, 
extremely high numbers of maternal deaths observed in 
two control districts during the preintervention period) 
and single facilities with reported numbers of deliveries 
missing for more than 40% of time points. The propor-
tion of omitted facilities was higher in the control (39%) 
compared with the intervention districts (18%). We 
further conducted sensitivity analyses comparing how 
different data cleaning decisions might have affected the 
resulting estimates, and found that results only very mini-
mally differed (data not shown) and thus not affected the 
overall findings of the study as reported here.
data analysis
We used multiple-group segmented linear regression to 
analyse the ITS21 comparing maternal mortality at birth 
between intervention and control districts, and between 
the preintervention (July 2012 until March 2013), early 
postintervention (April 2013 until September 2014) and 
late postintervention (October 2014 until March 2017) 
periods, according to the following model:
 
yt = β0 + β1Tt + β2z + β3zTt + β4x1
+β5x1Tt + β6zx1 + β7zx1Tt + β8x2
+β9x2Tt + β10zx2 + β11zx2Tt + εt ,  
where yt represents the maternal mortality outcome vari-
able measured at each monthly time point t, Tt a contin-
uous variable representing the months since observation 
start, x1 and x2 dummy variables representing each study 
period (x1=0 for t in the preintervention period; x1=1 
for t in the early and late postintervention periods; x2=0 
for t in the preintervention and early postintervention 
periods; x2=1 for t in the late postintervention period), 
and z a dummy variable representing the treatment 
group (0=control, 1=RBF). In this model,  β2  and  β3  indi-
cate the estimated differences in level (intercept) and 
slope (trend), respectively, of maternal mortality between 
treated and controls prior to the intervention;  β6  and  β7  
represent the estimated difference-in-differences in level 
and slope, respectively, attributable to the intervention 
during the early intervention period; and  β10  and  β11  
represent the estimated difference-in-differences in level 
and slope, respectively, attributable to the intervention 
during the late intervention period.
We defined two interruption points in our analysis 
to reflect the beginning of the two RBF4MNH inter-
vention phases in April 2014 and October 2014. Our 
model estimates the respective coefficients by Ordinary 
Least Squares (OLS) regression using Newey-West SEs to 
handle autocorrelation and potential heteroskedasticity. 
The Cumby-Huizinga test for autocorrelation22 demon-
strated the presence of serial autocorrelation up to a 
lag of 1; hence, we adjusted the model accordingly. In 
two separate sensitivity analyses (see online supplemen-
tary appendix), we adjusted the model to account for 
seasonality (hypothesised to affect labour patterns due 
to climate variability), and we estimated a more parsimo-
nious model based on district matching. Stata V.14.2 was 
used for all analyses.
Patient and public involvement statement
This study did not involve any patients.
resulTs
Sample characteristics are shown in table 1. The 23 
districts (4 intervention and 19 controls) contained a 
total of 456 health facilities offering obstetric care services 
for which HMIS data were available for more than 40% 
of observation points. Over the 57-month study period, a 
total of 23 964 complete observation points were included 
in the analysis. The average number of deliveries per 
month differed significantly between groups (p<0.01), 
but reported mortality rates were statistically not signif-
icantly different between groups and thus comparable 
during the preintervention period.
For the entire time series, the distribution of monthly 
observations by intervention and control districts is shown 
in the scatterplot in figure 1. Regression lines depict the 
predicted values of maternal mortality for each period. 
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Table 1 Sample distribution and sample characteristics
Characteristics Intervention Control Total
Total number of districts 4 19 23
Total number of health facilities 63 245 308
Total number of complete observations across 
all included facilities (entire study period)*
4948 18 980 23 964
Mean (SD) and median of monthly number of 
facility-based deliveries (entire study period)
65.4 (104.3)†, 37 61.4 (91.5)†, 34 62.2 (94.3), 35
Mean (SD) of monthly facility-based maternal 
deaths per 100 000 facility-based deliveries
    
  Preintervention period 158.0 (54.0) 120.7 (22.5) 139.3 (44.5)
  Postintervention period 1 158.4 (53.3)† 103.7 (21.8)† 131.0 (81.1)
  Postintervention period 1 123.5 (66.0)† 83.5 (24.9)† 103.5 (53.4)
*Complete information on both indicators (ie, number of monthly facility-based deliveries and monthly facility-based direct maternal deaths) 
feeding into outcome indicator for the entire study period.
†Difference in means statistically significant at 0.05 level (based on two-group t-test).
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Figure 1 Time trends of facility-based maternal mortality by district and months. Dots represent maternal mortality ratios 
averaged across facilities within each study arm (ie, intervention vs control); lines represent predicted maternal mortality ratio 
trends for each period based on linear regression.
Dashed vertical lines indicate the two interruption points. 
Intervention and control districts experienced similar 
declines in mortality levels and slopes between prein-
tervention and first postintervention periods. For both 
groups, mortality trends (slopes) in the first postinterven-
tion period were only slightly lower than the estimated 
mortality levels at the end of the postintervention period. 
Going from the end of the first to the beginning of the 
second postintervention period, neither intervention 
nor control districts experienced a statistically significant 
drop in estimated mortality rates. However, the inter-
vention districts experienced a marginally significantly 
greater decline in maternal mortality over the course of 
the later compared with the earlier intervention period.
Table 2 displays the results from the controlled ITS 
model. Maternal mortality at observation start (ie, July 
2012) was estimated at 111.4 deaths/100 000 facility-based 
deliveries for the control and 134.8 deaths/100 000 facil-
ity-based deliveries for the intervention districts. During 
the 9-month preintervention period, maternal mortality 
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Table 2 Effect of the RBF4MNH on facility-based maternal 
mortality
Estimated maternal deaths 
per 100 000 facility-based 
deliveries (95% CI)
Preintervention period
  Control level (July 2012) 111.4 (100.8 to 
122.0)*
  Difference in levels, 
intervention vs control 
(July 2012)
23.4 (−37.6 to 84.5)
  Control monthly trend 2.3 (−2.0 to 6.6)
  Difference of intervention 
vs control in trend change
3.5 (−12.2 to 19.1)
Effects related to phase 1 
(postintervention period 1)
  Control level change −29.8 (−63.9 to 4.2)*
  Difference of intervention 
vs control in level change
−28.9 (−119.4 to 61.7)
  Control monthly trend 
change
−2.2 (−6.7 to 2.4)
  Difference of intervention 
vs control in trend change
−0.1 (−17.8 to 17.7)
Effects related to phase 2 
(postintervention period 2)
  Control level change −10.8 (−34.7 to 13.1)
  Difference of intervention 
vs control in level change
−26.9 (−91.0 to 37.1)
  Control monthly trend 
change
−0.9 (−2.4 to 0.6)
  Difference of intervention 
vs control in trend change
−4.8 (−10.3 to 0.7)*
Estimates based on interrupted time-series analysis.
*P<0.1
RBF4MNH, Results-Based Financing For Maternal and Newborn 
Health Initiative.
increased by 2.3 deaths/100 000 facility-based deliveries 
per month in the control and by 5.8 deaths/100 000 
facility-based deliveries per month in the intervention 
districts. The differences between levels and trends were 
statistically not different, indicating that control and 
intervention districts were sufficiently comparable prior 
to the RBF4MNH intervention. During the first interven-
tion period, we observed a slope reduction attributable 
to the RBF4MNH of 0.1 fewer maternal deaths/100 000 
facility-based deliveries per month with an immediate 
reduction in maternal mortality levels (comparing the 
end of the preintervention with the beginning of the first 
postintervention period) attributable to the RBF4MNH 
of 28.9 deaths/100 000 facility-based deliveries. These 
effects, however, are not statistically significant. During 
the second postintervention period, we observed a 
marginally significant negative trend effect of 4.8 fewer 
deaths/100 000 facility-based deliveries per month 
attributable to the RBF4MNH, coupled with a statisti-
cally non-significant immediate reduction in maternal 
mortality attributable to the RBF4MNH of 26.9 deaths for 
every 100 000 facility-based deliveries. The results of the 
sensitivity analyses confirm the patterns observed in the 
primary analysis.
dIsCussIon
statement of principal findings
Our study makes a unique contribution to the existing 
literature being the first to assess the impact of a 
combined supply-side and demand-side RBF interven-
tion on facility-based maternal mortality at birth. The 
significant reduction by 4.8 deaths/100 000 deliveries 
(CI −10.3 to 0.7, p<0.1) per month attributable to the 
RBF4MNH intervention is remarkable considering that 
the intervention had been operative for only 4 years at 
the time of evaluation.
strengths and weaknesses of the study
With under-reporting of maternal deaths being likely in 
both intervention and control facilities, our mortality 
estimates are probably rather conservative. Throughout 
the study period, monthly average ratios of facility-based 
maternal mortality were higher and more fluctuating 
in the intervention compared with the control districts 
(figure 1). In fact, the numbers of birth-related deaths 
varied greatly for any given facility when measured 
monthly. This fluctuation was more pronounced in the 
four intervention districts given their smaller sample size 
compared with the control arm. The higher mortality in 
the four intervention districts might be explained by the 
non-random selection of the RBF4MNH districts,14 and 
the RBF4MNH incentives to improve HMIS reporting, 
perhaps reducing previous under-reporting of birth-re-
lated maternal deaths in the intervention facilities, might 
explain the higher mortality observed in the four inter-
vention districts.15
The similarity in trends and levels in both study groups 
during the preintervention and first postinterven-
tion periods likely demonstrates a pre-existing general 
decline in maternal mortality that continued far into the 
initial programme phase (April 2013–September 2014). 
This could be an indication of both the programme’s 
limited capacity to produce any measurable effects in 
its early phase and the existence of a nationwide secular 
trend. In fact, early intervention was characterised by 
several adjustments to the initial design, eventually 
improving the programme’s operational capacity prior 
to expansion.15 23 Coexistence of many independent 
MNH programmes across Malawi during the pre-2015 
period could explain the presence of a secular trend.24 
Also, given the relatively high mortality rates observed in 
the intervention districts, we cannot determine to what 
extent the observed effect size would have been different 
in scenarios with higher or lower baseline levels prior to 
intervention start.
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strengths and weaknesses in relation to other studies
The size of the impact on mortality identified in this 
study was surprising given our prior analyses of the 
programme’s effect on intermediate outcomes based on a 
controlled pre–post test design using primary data. While 
we found significant improvements in equipment main-
tenance and selected drugs and consumables (ranging 
between 9% and 52% point increases for selected items), 
RBF4MNH effects were less conclusive or less extensive 
in terms of birth attendants’ adherence to obstetric treat-
ment protocols (for instance, non-significant increases 
between 8% and 21% points in activities related to infec-
tion prevention, accompanied by decreases between 
18% and 46% points for activities related to postpartum 
haemorrhage prevention)16 and effective childbirth care 
coverage (increase by 7.1% points with a p=0.07 in effec-
tive coverage).17
Three factors may explain this discrepancy. First, our 
prior analyses used endline data collected only 2 years 
after the RBF4MNH launch compared with 48 months in 
this ITS analysis. This analysis confirms that RBF4MNH 
gains were not yet realised in the 2 years after programme 
launch and were mainly accrued later once the interven-
tion had reached its full operational capacity. Second, 
the RBF4MNH might have produced changes in service 
quality early on that our previous studies failed to capture, 
and those early changes led to remarkable reduction in 
maternal mortality later on. Third, with 62% of maternal 
deaths in Malawi occurring during the early postpartum 
period,25 the combined demand-side and supply-side 
effect of the RBF4MNH encouraging both women and 
providers to remain at facilities for the 48-hour post-
partum observation period15 likely removed pre-existing 
delays in postpartum care-seeking (not focus of our prior 
work).26
Meaning of the study
The observed reduction in maternal mortality is highly 
relevant from a policy point of view. Although remarkable 
reductions,27 Malawi continues to experience high rates 
of maternal mortality.11 About 71% of maternal deaths in 
Malawi occur around the time of birth and 63% among 
women who delivered in a facility.25 A recent survey indi-
cated that 62% of maternal deaths occurred at health 
facilities and an additional 21% among mothers who 
just returned home after delivering in a facility.26 Hence, 
reducing facility-based maternal deaths at birth by acting to 
improve quality of service delivery and extending women’s 
in-hospital stays is likely to bear an important impact on the 
country’s overall maternal mortality, considering Malawi’s 
situation with over 90% of women giving birth at a facility11 
in the context of poor obstetric care quality.28 29 However, 
we cannot fully appraise the mortality reduction produced 
by the RBF4MNH in relation to other maternal care inter-
ventions due to the current lack of comparable studies.
unanswered questions and future research
Our study inevitably suffers from a number of limita-
tions. First, reliance on HMIS data implied that overall 
reductions in population-based maternal mortality could 
not be estimated. Given the crucial role quality obstetric 
care plays in shaping maternal health outcomes beyond 
the early postpartum period, it is plausible to assume that 
the RBF4MNH is likely to have produced broader impacts 
on overall maternal mortality. Further research relying 
on other data sources is needed to test this hypothesis.
Second, due to extremely poor quality of HMIS data 
with extreme proportions of missing values on newborn 
outcomes, we were unable to assess the impact of the 
RBF4MNH on neonatal mortality. While the DHIS-2 plat-
form likely contributed to improved HMIS data quality 
in Malawi (especially for Millennium Development 
Goal-relevant indicators, such as facility-based deliveries 
and related direct maternal deaths),30 31 and although 
the assuring findings of our sensitivity analysis regarding 
our data cleaning approach, the fact that we still had to 
exclude single facilities due to poor data quality might 
have biased our findings. This is unfortunate given that 
improving delivery and early neonatal care is likely to 
bear a more visible impact on neonatal than maternal 
mortality.32
Third, while the quasi-experimental application of 
the ITS allowed us to establish causality between the 
RBF4MNH and maternal mortality, additional non-ob-
served confounders (eg, maternal health programmes 
with local or regional effects) might have biased our 
estimates. To our knowledge, however, the only other 
large programme likely to have produced changes in 
health system structures capable of inducing changes in 
maternal mortality is the Support for Service Delivery 
Integration, a United States Agency for International 
Development-funded programme implemented in 
parallel to the RBF4MNH,33 which we think is unlikely to 
have shaped results since it was implemented in one of 
four RBF districts but in 14 controls. If so, our analysis is 
likely to have produced lower bound estimates of the true 
effect of the RBF4MNH Initiative.
Fourth, in spite of the observed completeness of 
HMIS data on maternal deaths, we need to acknowledge 
the possibility that providers may under-report deaths. 
Again, however, such under-reporting does not invali-
date our analysis, since we have no reason to imagine that 
under-reporting differs systematically between interven-
tion and control facilities and/or districts.
Last, we need to acknowledge the limited generalis-
ability of our findings to other RBF settings. Unlike most 
other RBF programmes where payments linked to quan-
tity aspects of service delivery dominate,34 the RBF4MNH 
kept a stronger focus on payments linked to quality of 
care processes, such as drug and supply procurement, 
equipment maintenance, routine death audits and 
selected aspects of clinical case management. We there-
fore need to caution the reader when extrapolating our 
results to other RBF settings.
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